Skip to main content

Capital World Investors

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1422849 LOS ANGELES, CA

Position in KALV

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$56,536,775
+$11,178,160 QoQ
Shares Held
2,808,583
0.0% QoQ
Ownership
5.28%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 182 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in KALV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capital World Investors holds $23,534,298,325 across 32 Biotechnology names. KALV ranks #17 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KALV

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $56,536,775 2,808,583
2025-12-31 $45,358,615 2,808,583
2025-09-30 $38,703,009 3,177,587
2025-06-30 $35,922,621 3,177,587
2025-03-31 $36,669,353 3,177,587
2024-12-31 $28,578,322 3,374,064
2024-09-30 $39,071,661 3,374,064
2024-06-30 $38,021,363 3,227,620
2024-03-31 $17,370,227 1,464,606